NGM · Medical - Devices

TELA Bio, Inc. (TELA) Stock

$1.11 +5.71% NGM: TELA Healthcare

Valuation

MetricValue
Price$1.11
Market Cap$49.66M
P/E Ratio-1.39
P/B Ratio-3.87
P/S Ratio0.60
EPS (TTM)$-0.83
52-Week High$1.60
52-Week Low$0.50
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-650.00%
ROA-68.93%
ROCE-81.91%
Gross Margin-42.50%
Operating Margin-42.50%
Net Margin-51.53%
Debt/Equity-3.57
Current Ratio4.22

Annual Financials (USD)

Metric20212022202320242025
Revenue$29.0M$41.0M$58.0M$69.0M$80.0M
Operating Profit$-29.0M$-39.0M$-44.0M$-34.0M$-34.0M
Net Profit$-33.0M$-44.0M$-47.0M$-38.0M$-39.0M
EPS$-2.30$-2.73$-2.04$-1.33$-0.83
Op Margin-100.0%-94.2%-75.4%-49.2%-42.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$63.0M$68.0M$78.0M$87.0M$81.0M
Total Liabilities$42.0M$54.0M$59.0M$59.0M$75.0M
Cash$44.0M$42.0M$47.0M$53.0M$51.0M
Borrowings$31.0M$41.0M$43.0M$43.0M$56.0M

Latest News

TELA Bio to Announce Second Quarter 2026 Financial Results GlobeNewswire · Jul 20, 2026 Earnings Release: Here's Why Analysts Cut Their TELA Bio, Inc. (NASDAQ:TELA) Price Target To US$2.25 Simply Wall St. · May 15, 2026 TELA Bio, Inc. Q1 2026 Earnings Call Summary Moby · May 13, 2026 TELA Bio Inc (TELA) Q1 2026 Earnings Call Highlights: Strong European Growth and Strategic U.S. ... GuruFocus.com · May 13, 2026 TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates Zacks · May 12, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-30.0M$-41.0M$-41.0M$-42.0M$-28.0M
Investing Cash Flow$-1.0M$-4.0M$-1.0M$3.0M$0
Financing Cash Flow$0$-4.0M$0$0$0
Net Cash Flow$-30.0M$-2.0M$5.0M$6.0M$-2.0M
Free Cash Flow$-31.0M$-43.0M$-41.0M$-43.0M$-29.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.04
EV / EBITDA-2.24
FCF Yield-66.05%
Quick Ratio2.38
Interest Coverage-11.89
Return 1Y-61.11%
Return 3Y-92.18%
Return 5Y-94.66%

Ownership

Insiders Held7.71%
Institutions Held68.96%
Institutions Float Held74.72%
Institutional HolderSharesReport Date
Essex Woodlands Management Inc.7,714,7092026-03-31
Nantahala Capital Management, LLC5,144,1142026-03-31
Stonepine Capital Management, LLC2,617,2522026-03-31
SilverArc Capital Management, LLC2,259,3122026-03-31
Vanguard Capital Management LLC1,540,6242026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About TELA Bio, Inc.

TELA Bio, Inc. is led by CEO Antony Koblish, employs 209 people, headquartered in US, publicly traded since 2019.

TELA Bio, Inc. (TELA) stock trades at $1.11 with a market capitalization of $49.66M. The stock is valued at a price-to-earnings (P/E) ratio of -1.39, price-to-book of -3.87, price-to-sales of 0.60. Over the past 52 weeks the stock has ranged between $0.50 and $1.60, and currently trades 30.6% below its 52-week high.

On profitability, TELA Bio, Inc. generates a return on equity (ROE) of -650.00%, return on capital employed of -81.91%, an operating margin of -42.50%, a net profit margin of -51.53%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.31 +0.33% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides